A Study of BMS-986484 Alone and Combination Therapy in Participants With Advanced Solid Tumors

Recruiting

Phase 1

BMS-986484A Study of BMS-986484 Alone and Combination Therapy in Participants With Advanced Solid Tumors

Sponsor:

Bristol-Myers Squibb

Code:

NCT06544655

Conditions

Advanced Solid Tumors

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

BMS-986484

Nivolumab

Oxaliplatin

Capecitabine

Fluorouracil

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-09. This information was provided to ClinicalTrials.gov by Bristol-Myers Squibb on 2025-10-21.